Taiwan Diabetes Registry

NCT06143449 · tracked via the Priya Life Science China tracker

Sponsor

The Diabetes Association of the Republic of China (Taiwan)

Phase

Observational

Started

2015-10-01

Last updated

2023-11-29

Condition(s) studied

Diabetes Mellitus

Investigational drug(s) / intervention(s)

Observational study - registry

Observational study - registry: Observational study - registry

Study summary

To Investigate the Risk Factors, Life Style and Treatments of the Microvascular Disease，Macrovascular Disease and Neuropathy in Patients With Diabetes.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Diagnosis of diabetes mellitus Exclusion Criteria: * Patients who do not have diabetes mellitus * Participating in an interventional trial requiring informed consent

Primary outcome measure(s)

Provide data on patient characteristics — Ten years
Provide data on disease management. — Ten years

Trial sites (1)

Facility	City	Region	Status
The Diabetes Association of the Republic of China (Taiwan)	Taipei	Taiwan	Recruiting

Other trials for the same condition

Goal Commitment and Proactive Health Behavior in Chronic Disease Patients Recruiting

Shanghai Children and Adolescent Diabetes Eye Study Recruiting

Taining Golden Lake Comprehensive Chronic Disease Management Initiative Recruiting

Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation Starting soon

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06143449 on ClinicalTrials.gov ↗ ← All trials in China